Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections. It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was founded in 2021 and is based in Rellingen, Germany.
11 transactions — 1 buys and 10 sales reported by Viromed Medical AG executives.
0 institutional funds report a position on VME in their latest SEC quarterly filing.
5 recent articles on VME.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of VME on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year